These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31010867)

  • 1. Comparing Antimicrobial Susceptibilities among
    Oishi T; Takahashi K; Wakabayashi S; Nakamura Y; Ono S; Kono M; Kato A; Saito A; Kondo E; Tanaka Y; Teranishi H; Akaike H; Tanaka T; Miyata I; Ogita S; Ohno N; Nakano T; Ouchi K
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.
    Tanaka T; Oishi T; Miyata I; Wakabayashi S; Kono M; Ono S; Kato A; Fukuda Y; Saito A; Kondo E; Teranishi H; Tanaka Y; Wakabayashi T; Akaike H; Ogita S; Ohno N; Nakano T; Terada K; Ouchi K
    Emerg Infect Dis; 2017 Oct; 23(10):1703-1706. PubMed ID: 28930026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Efficacy of Antimicrobial Agents Among Hospitalized Patients With Mycoplasma pneumoniae Pneumonia in Japan During Large Epidemics of Macrolide-Resistant M. pneumoniae Infections: A Nationwide Observational Study.
    Tashiro M; Fushimi K; Kawano K; Takazono T; Saijo T; Yamamoto K; Kurihara S; Imamura Y; Miyazaki T; Yanagihara K; Mukae H; Izumikawa K
    Clin Infect Dis; 2017 Nov; 65(11):1837-1842. PubMed ID: 29020161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic diversity and macrolide resistance of Mycoplasma pneumoniae isolates from two consecutive epidemics in Slovenia.
    Kogoj R; Praprotnik M; Mrvič T; Korva M; Keše D
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):99-107. PubMed ID: 28948376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan.
    Matsuda K; Narita M; Sera N; Maeda E; Yoshitomi H; Ohya H; Araki Y; Kakuma T; Fukuoh A; Matsumoto K
    BMC Infect Dis; 2013 Dec; 13():591. PubMed ID: 24330612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycoplasma pneumoniae isolated from patients with respiratory infection in Kanagawa Prefecture in 1976-2006: emergence of macrolide-resistant strains.
    Okazaki N; Ohya H; Sasaki T
    Jpn J Infect Dis; 2007 Sep; 60(5):325-6. PubMed ID: 17881881
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014.
    Kogoj R; Mrvic T; Praprotnik M; Kese D
    Euro Surveill; 2015; 20(37):. PubMed ID: 26536357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia.
    Morozumi M; Takahashi T; Ubukata K
    J Infect Chemother; 2010 Apr; 16(2):78-86. PubMed ID: 20094751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011.
    Uldum SA; Bangsborg JM; Gahrn-Hansen B; Ljung R; Mølvadgaard M; Føns Petersen R; Wiid Svarrer C
    Euro Surveill; 2012 Feb; 17(5):. PubMed ID: 22321137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase-shifting of the transmissibility of macrolide-sensitive and resistant Mycoplasma pneumoniae epidemics in Hong Kong, from 2015 to 2018.
    Zhao S; Musa SS; Qin J; He D
    Int J Infect Dis; 2019 Apr; 81():251-253. PubMed ID: 30822543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients.
    Matsubara K; Morozumi M; Okada T; Matsushima T; Komiyama O; Shoji M; Ebihara T; Ubukata K; Sato Y; Akita H; Sunakawa K; Iwata S
    J Infect Chemother; 2009 Dec; 15(6):380-3. PubMed ID: 20012728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Mycoplasma pneumoniae infection identified on culture in a pediatric clinic.
    Katsushima Y; Katsushima F; Suzuki Y; Seto J; Mizuta K; Nishimura H; Matsuzaki Y
    Pediatr Int; 2015 Apr; 57(2):247-52. PubMed ID: 25265270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of 11 antimicrobial agents against macrolide-resistant Mycoplasma pneumoniae isolates from pediatric patients: results from a multicenter surveillance study.
    Akaike H; Miyashita N; Kubo M; Kawai Y; Tanaka T; Ogita S; Kawasaki K; Nakano T; Terada K; Ouchi K;
    Jpn J Infect Dis; 2012; 65(6):535-8. PubMed ID: 23183207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.
    Cao B; Qu JX; Yin YD; Eldere JV
    Clin Respir J; 2017 Jul; 11(4):419-429. PubMed ID: 26365811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence Type Changes Associated with Decreasing Macrolide-Resistant Mycoplasma pneumoniae, Japan.
    Morozumi M; Tajima T; Sakuma M; Shouji M; Meguro H; Saito K; Iwata S; Ubukata K
    Emerg Infect Dis; 2020 Sep; 26(9):2210-2213. PubMed ID: 32818419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients.
    Kawai Y; Miyashita N; Kubo M; Akaike H; Kato A; Nishizawa Y; Saito A; Kondo E; Teranishi H; Wakabayashi T; Ogita S; Tanaka T; Kawasaki K; Nakano T; Terada K; Ouchi K
    Antimicrob Agents Chemother; 2013 Aug; 57(8):4046-9. PubMed ID: 23716043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental and clinical studies of sparfloxacin in Mycoplasma pneumoniae infection.
    Kaku M; Ishida K; Kohno S; Koga H; Hara K; Usui T
    Drugs; 1995; 49 Suppl 2():412-3. PubMed ID: 8549381
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology and mechanism of drug resistance of Mycoplasma pneumoniae in Beijing, China: A multicenter study.
    Guo DX; Hu WJ; Wei R; Wang H; Xu BP; Zhou W; Ma SJ; Huang H; Qin XG; Jiang Y; Dong XP; Fu XY; Shi DW; Wang LY; Shen AD; Xin DL
    Bosn J Basic Med Sci; 2019 Aug; 19(3):288-296. PubMed ID: 30878034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimycoplasmal activities of new quinolones, tetracyclines, and macrolides against Mycoplasma pneumoniae.
    Arai S; Gohara Y; Kuwano K; Kawashima T
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1322-4. PubMed ID: 1416832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009.
    Suzuki Y; Itagaki T; Seto J; Kaneko A; Abiko C; Mizuta K; Matsuzaki Y
    Pediatr Infect Dis J; 2013 Mar; 32(3):237-40. PubMed ID: 23114374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.